The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Mederle, Katharina ^a   Schweda, Frank ^a   Kattler, Veronika ^a   Doblinger, Elisabeth ^a   Miyata, Keishi ^b   Höcherl, Klaus ^a   Oike, Yuichi ^b   Castrop, Hayo ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ASSOCIATED PROTEIN; ANGIOTENSIN II; GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AGTRAP PROTEIN, MOUSE; RENIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE COURSE; ENDOTOXEMIA; GENE EXPRESSION; GENOTYPE; GLOMERULUS FILTRATION RATE; HYPOTENSION; IN VITRO STUDY; MESANGIUM CELL; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SEPSIS; SEPSIS INDUCED HYPOTENSION; TELEMETRY; VASCULAR RESISTANCE; WILD TYPE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; DOWN REGULATION; KIDNEY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECRETION (PROCESS);

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOOD PRESSURE; DOWN-REGULATION; HYPOTENSION; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MICE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SEPSIS;

EID: 84880007805     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12809     Document Type: Article

References (28)

1. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595. 10.1056/NEJMra002709, 11529214.
2. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169. 10.1056/NEJMra032401, 15247356.
3. Benedict CR, Rose JA. Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992, 38:165-172.
4. Cumming AD, Driedger AA, McDonald JW, Lindsay RM, Solez K, Linton AL. Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 1988, 11:23-32.
5. Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M. Renin-angiotensin system in sepsis. Clin Exp Hypertens A 1987, 9:1493-1504.
6. Ohtani R, Ohashi Y, Muranaga K, Itoh N, Okamoto H. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci 1989, 44:237-241. 10.1016/0024-3205(89)90601-2, 2644507.
7. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991, 214:621-626. 10.1097/00000658-199111000-00013, 1358619, 1953116.
8. Castrop H. Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system. Pflugers Arch 2013, 465:111-119. 10.1007/s00424-012-1113-z, 22588461.
9. Du G, Huang P, Liang BT, Frohman MA. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell 2004, 15:1024-1030. 363061, 14718562.
10. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996, 36:281-306. 10.1146/annurev.pa.36.040196.001433, 8725391.
11. Gunther S, Gimbrone MA, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 1980, 287:230-232. 10.1038/287230a0, 6253796.
12. Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 1994, 24:523-527. 10.1161/01.HYP.24.4.523, 8088922.
13. Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem 1996, 271:13266-13272. 10.1074/jbc.271.22.13266, 8662816.
14. Castrop H, Hocherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology of kidney renin. Physiol Rev 90:607-673.
15. Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M, Dzau VJ. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 1999, 274:17058-17062. 10.1074/jbc.274.24.17058, 10358057.
16. Lopez-Ilasaca M, Liu X, Tamura K, Dzau VJ. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 2003, 14:5038-5050. 10.1091/mbc.E03-06-0383, 284805, 12960423.
17. Guo DF, Chenier I, Tardif V, Orlov SN, Inagami T. Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun 2003, 310:1254-1265. 10.1016/j.bbrc.2003.09.154, 14559250.
18. Doblinger E, Hocherl K, Mederle K, Kattler V, Walter S, Hansen PB, Jensen B, Castrop H. Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II. Am J Physiol Renal Physiol 2012, 302:F1313-1324. 10.1152/ajprenal.00620.2011, 22357923.
19. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, Urano T, Zhu HJ, Tsukano H, Tazume H, Kaikita K, Miyashita K, Iwawaki T, Shimabukuro M, Sakaguchi K, Ito T, Nakagata N, Yamada T, Katagiri H, Kasuga M, Ando Y, Ogawa H, Mochizuki N, Itoh H, Suda T, Oike Y. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009, 10:178-188. 10.1016/j.cmet.2009.08.003, 19723494.
20. Oppermann M, Gess B, Schweda F, Castrop H. Atrap deficiency increases arterial blood pressure and plasma volume. J Am Soc Nephrol 2010, 21:468-477. 10.1681/ASN.2009060658, 2831856, 20093357.
21. Castrop H, Huang Y, Hashimoto S, Mizel D, Hansen P, Theilig F, Bachmann S, Deng C, Briggs J, Schnermann J. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice. J Clin Invest 2004, 114:634-642. 514589, 15343381.
22. Oppermann M, Friedman DJ, Faulhaber-Walter R, Mizel D, Castrop H, Enjyoji K, Robson SC, Schnermann J. Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. Am J Physiol Renal Physiol 2008, 294:F965-970. 10.1152/ajprenal.00603.2007, 18256308.
23. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 2009, 37:626-633. 10.1097/CCM.0b013e3181958d91, 19114890.
24. van Eijk LT, Nooteboom A, Hendriks T, Sprong T, Netea MG, Smits P, van der Hoeven JG, Pickkers P. Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock 2006, 25:358-362. 10.1097/01.shk.0000209527.35743.b0, 16670637.
25. Gardiner SM, Kemp PA, March JE, Bennett T. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats. Br J Pharmacol 1996, 119:1619-1627. 10.1111/j.1476-5381.1996.tb16081.x, 1915803, 8982510.
26. Guo DF, Chenier I, Lavoie JL, Chan JS, Hamet P, Tremblay J, Chen XM, Wang DH, Inagami T. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 2006, 48:453-459. 10.1161/01.HYP.0000230664.32874.52, 16801480.
27. Cole JM, Khokhlova N, Sutliff RL, Adams JW, Disher KM, Zhao H, Capecchi MR, Corvol P, Bernstein KE. Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II. Hypertension 2003, 41:313-321. 10.1161/01.HYP.0000050650.52007.83, 12574101.
28. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA 1998, 95:15496-15501. 10.1073/pnas.95.26.15496, 28071, 9860997.